Loading…
Loading grant details…
| Funder | Vinnova |
|---|---|
| Recipient Organization | Vitrosorb Ab |
| Country | Sweden |
| Start Date | Jun 01, 2024 |
| End Date | Jan 31, 2025 |
| Duration | 244 days |
| Number of Grantees | 1 |
| Roles | Principal Investigator |
| Data Source | Swedish Research Council |
| Grant ID | 2024-00417_Vinnova |
Purpose and goal: ** Denna text är maskinöversatt **
The project aims to evaluate whether cellulose-based nonwovens can be used as a sustainable bio-based material for immunoadsorption. The main goal of the project is to evaluate the technical conditions for the material (plasma filtration). The market and sustainability conditions will also be examined in terms of the competitive situation and manufacturing scale-up.
Expected results and effects: ** Denna text är maskinöversatt **
VitroSorb´s vision is that the project should lead to an efficient, durable and cheap immunoadsorption product. More specifically, the goal is to develop technology for the production of universal plasma, which enables, for example, blood transfusions and organ transplants between different blood groups. Such next-generation immunoadsorption products could reach new major markets.
To reach commercialization, the IP for the functionalized end product will vest with VitroSorb and be protected by a project agreement. Approach and implementation: ** Denna text är maskinöversatt **
The project is divided into 4 work packages where WP1-3 aim to develop and test the cellulose-based nonwoven material for the removal of immunoglobulin G from human blood. RISE is responsible for the production of cellulose nonwovens with the solution blown technique (WP1) and its potential scale-up (WP4), while VitroSorb is responsible for ligand functionalization (WP2), testing the immunoadsorption capacity (WP3) and the market potential (WP4).
Vitrosorb Ab
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant